6. パーキンソン病 Parkinson disease Clinical trials / Disease details

臨床試験数 : 2,307 / 薬物数 : 2,007 - (DrugBank : 349) / 標的遺伝子数 : 188 - 標的パスウェイ数 : 199

3 trials found

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT00387075 (ClinicalTrials.gov)	November 2006	10/10/2006	A Study Evaluating Potential Screening Tools for Detecting Parkinson Disease	Parkinson Associated Risk Factor Study (PARS): Evaluating Potential Screening Tools for Parkinson Disease	Parkinson Disease	Procedure: [123I]ß-CIT and SPECT imaging;Drug: [123I]ß-CIT	Institute for Neurodegenerative Disorders	United States Department of Defense;Molecular NeuroImaging	Active, not recruiting	50 Years	N/A	All	3000	Phase 2	United States
2	NCT00096720 (ClinicalTrials.gov)	February 2004	12/11/2004	Study of the Effects of Dopaminergic Medications on Dopamine Transporter Imaging in Parkinson's Disease	Investigating Effects of Short-term Treatment With Pramipexole or Levodopa on [123I]B-CIT and SPECT Imaging in Early Parkinson's	Parkinson Disease;Parkinsonian Syndrome	Drug: levodopa;Drug: Mirapex (pramipexole);Procedure: [123I]ß-CIT and SPECT imaging	Institute for Neurodegenerative Disorders	Boehringer Ingelheim;Department of Defense	Completed	30 Years	N/A	Both	112	Phase 2	United States
3	NCT00132626 (ClinicalTrials.gov)	September 1992	18/8/2005	Study of Brain Imaging With Nuclear Technology in Individuals With Parkinsonian Syndrome	Dynamic SPECT Imaging With [123I]ß-CIT in Patients With Parkinsonism	Parkinson's Disease;Parkinsonian Syndrome	Drug: [123I]ß-CIT and SPECT imaging	Institute for Neurodegenerative Disorders	Molecular NeuroImaging;National Institutes of Health (NIH)	Completed	35 Years	N/A	All	500	Phase 2	NULL